Citation Impact 2023
Journal Impact Factor: 4.4
5-year Journal Impact Factor: 4.9
Source Normalized Impact per Paper (SNIP): 1.294
SCImago Journal Rank (SJR): 1.518
Speed 2023
Submission to first editorial decision (median days): 9
Submission to acceptance (median days): 111
Usage 2023
Downloads: 3,331,819
Altmetric mentions: 1,885
Articles
Page 129 of 155
-
Citation: Arthritis Res Ther 2004 6:E2
-
Decreased levels of soluble amyloid β-protein precursor and β-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosus
Symptoms originating from the central nervous system (CNS) frequently occur in patients with systemic lupus erythematosus (SLE). These symptoms are extremely diverse, including a state of dementia. The aim of ...
Citation: Arthritis Res Ther 2004 6:R129 -
IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-κB- and PI3-kinase/Akt-dependent pathways
Recent studies of the pathogenesis of rheumatoid arthritis (RA) have revealed that both synovial fibroblasts and T cells participate in the perpetuation of joint inflammation as dynamic partners in a mutual ac...
Citation: Arthritis Res Ther 2004 6:R120 -
Signal 3 and its role in autoimmunity
Citation: Arthritis Res Ther 2004 6:26 -
Susceptibility to collagen-induced arthritis is modulated by TGFβ responsiveness of T cells
The objective of our study was to determine the regulatory effects that endogenous transforming growth factor β (TGFβ) exerts on T cells in the pathogenesis of collagen-induced arthritis (CIA). CIA was induced...
Citation: Arthritis Res Ther 2004 6:R114 -
Inhibition of established collagen-induced arthritis with a tumour necrosis factor-α inhibitor expressed from a self-contained doxycycline regulated plasmid
Tumor necrosis factor (TNF)-α is produced by cells of the immune system and is a key mediator in immune and inflammatory reactions. Through interaction with widely expressed receptors (TNF receptor 1 and TNF r...
Citation: Arthritis Res Ther 2003 6:R103 -
A paragon of self-tolerance: CD25+CD4+regulatory T cells and the control of immune responses
The interest in naturally arising regulatory T (TR) cells as a paradigm for maintaining immunological self-tolerance has undergone an explosive re-emergence in recent years. This renaissance was triggered by seve...
Citation: Arthritis Res Ther 2003 6:19 -
Evidence for early disease-modifying drugs in rheumatoid arthritis
Some research evidence supports early aggressive treatment of rheumatoid arthritis (RA) using combination therapy with two or more disease modifying anti-rheumatic drugs (DMARDs) plus steroids, or even DMARDs ...
Citation: Arthritis Res Ther 2003 6:15 -
Giantin is the major Golgi autoantigen in human anti-Golgi complex sera
Anti-Golgi complex antibodies (AGAs) are primarily associated with systemic lupus erythematosus and Sjögren's syndrome. Here we report on the immunoreactivity of AGAs against five Golgi autoantigens (giantin, ...
Citation: Arthritis Res Ther 2003 6:R95 -
Natural killer cells and autoimmunity
Autoimmune diseases are often characterized as clinical syndromes caused by the inappropriate activation of T or B cells resulting in systemic or organ-specific damage. However, studies support a role for the ...
Citation: Arthritis Res Ther 2003 6:8 -
Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus
This study was performed to investigate the relation between IgG autoantibodies against human C-reactive protein (anti-CRP) and disease activity measures in serial serum samples from 10 patients with systemic ...
Citation: Arthritis Res Ther 2003 6:R87 -
Autoimmune response in cartilage-delivered peptides in a patient with osteoarthritis
Whatever the initiating factor of osteoarthritis (OA), the process ultimately unmasks the immunogenic determinants of chondrocytes, proteoglycans and collagens, which then triggers autoimmune reactions. Althou...
Citation: Arthritis Res Ther 2003 6:6 -
B cell abnormalities in systemic lupus erythematosus
Systemic lupus erythematosus (SLE) is a chronic, multisystem autoimmune disease characterized by the differentiation of short- and long-lived immunoglobulin secreting plasma cells that secrete pathogenic autoa...
Citation: Arthritis Res Ther 2003 5(Suppl 4):S22 -
Safety of rituximab in the treatment of B cell malignancies: implications for rheumatoid arthritis
The chimeric anti-CD20 monoclonal antibody rituximab has been used extensively in the treatment of B cell malignancies, and more recently it has emerged as a potential treatment for rheumatoid arthritis (RA), ...
Citation: Arthritis Res Ther 2003 5(Suppl 4):S12 -
Roles of B cells in rheumatoid arthritis
B lymphocytes play several critical roles in the pathogenesis of rheumatoid arthritis. They are the source of the rheumatoid factors and anticitrullinated protein antibodies, which contribute to immune complex...
Citation: Arthritis Res Ther 2003 5(Suppl 4):S1 -
Citrullination, a possible functional link between susceptibility genes and rheumatoid arthritis
Antibodies directed to citrullinated proteins (anti-cyclic citrullinated peptide) are highly specific for rheumatoid arthritis (RA). Recent data suggest that the antibodies may be involved in the disease proce...
Citation: Arthritis Res Ther 2003 6:1 -
The 4th annual European League Against Rheumatism congress in Lisbon: a personal perspective
The 4th annual European League Against Rheumatism congress, held in Lisbon, 18–21 June 2003, had a record turnout of more than 8600 delegates and the abstract submissions increased to 2600. A heat wave and a s...
Citation: Arthritis Res Ther 2003 6:E1 -
Articles selected from Faculty of 1000 in November 2003
Citation: Arthritis Res Ther 2003 5:E3 -
Enhanced expression of interferon-inducible protein 10 associated with Th1 profiles of chemokine receptor in autoimmune pulmonary inflammation of MRL/lprmice
MRL/Mp-lpr/lpr (MRL/lpr) mice spontaneously develop systemic lupus erythematosus (SLE)-like disease. The natural history of the pulmonary involvement and the underlying mechanism of leukocyte infiltration into th...
Citation: Arthritis Res Ther 2003 6:R78 -
Does protein kinase R mediate TNF-α- and ceramide-induced increases in expression and activation of matrix metalloproteinases in articular cartilage by a novel mechanism?
We investigated the role of the proinflammatory cytokine TNF-α, the second messenger C2-ceramide, and protein kinase R (PKR) in bovine articular cartilage degradation. Bovine articular cartilage explants were sti...
Citation: Arthritis Res Ther 2003 6:R46 -
A randomized, controlled trial of interferon-β-1a (Avonex®) in patients with rheumatoid arthritis: a pilot study [ISRCTN03626626]
The objective of this study was to evaluate the safety and possible efficacy of IFN-β-1a for the treatment of patients with rheumatoid arthritis (RA). Twenty-two patients with active RA were enrolled in a phas...
Citation: Arthritis Res Ther 2003 6:R73 -
Attenuation of inflammatory polyarthritis in TNF transgenic mice by diacerein: comparative analysis with dexamethasone, methotrexate and anti-TNF protocols
The impact of diacerein, an effective cartilage targeted therapy that is used in patients with osteoarthritis, on the development and progression of chronic inflammatory arthritis was evaluated in a tumor necr...
Citation: Arthritis Res Ther 2003 6:R65 -
Chondrocyte response to growth factors is modulated by p38 mitogen-activated protein kinase inhibition
Inhibitors of p38 mitogen-activated protein kinase (MAPK) diminish inflammatory arthritis in experimental animals. This may be effected by diminishing the production of inflammatory mediators, but this kinase ...
Citation: Arthritis Res Ther 2003 6:R56 -
Novel approaches to gene expression analysis of active polyarticular juvenile rheumatoid arthritis
Juvenile rheumatoid arthritis (JRA) has a complex, poorly characterized pathophysiology. Modeling of transcriptosome behavior in pathologic specimens using microarrays allows molecular dissection of complex au...
Citation: Arthritis Res Ther 2003 6:R15 -
Decreased response to IL-12 and IL-18 of peripheral blood cells in rheumatoid arthritis
Inflamed synovium of rheumatoid arthritis (RA) has been associated with a T helper (Th)1 cytokine profile but the blood situation remains to be clarified. We studied the differential IFN-γ producing activity o...
Citation: Arthritis Res Ther 2003 6:R39 -
Anti-α-fodrin antibodies do not add much to the diagnosis of Sjögren's syndrome
The presence of anti-α-fodrin autoantibodies has been reported to be a highly specific and sensitive test for the diagnosis of Sjögren's syndrome (SjS). We looked (in Nijmegen) for anti-α-fodrin, anti-Ro60, an...
Citation: Arthritis Res Ther 2003 6:R33 -
Intramuscular electroporation with the pro-opiomelanocortin gene in rat adjuvant arthritis
Endogenous opioid peptides have an essential role in the intrinsic modulation and control of inflammatory pain, which could be therapeutically useful. In this study, we established a muscular electroporation m...
Citation: Arthritis Res Ther 2003 6:R7 -
Ageing, autoimmunity and arthritis: Perturbations of TCR signal transduction pathways with ageing – a biochemical paradigm for the ageing immune system
It is widely accepted that cell-mediated immune functions decline with age, rendering an individual more susceptible to infection and possibly cancer, as well as to age-associated autoimmune diseases. The exac...
Citation: Arthritis Res Ther 2003 5:290 -
Leukotrienes, mast cells, and T cells
Citation: Arthritis Res Ther 2003 5:288 -
Microarray analysis of gene expression in lupus
Recent advances in the study of global patterns of gene expression with the use of microarray technology, coupled with data analysis using sophisticated statistical algorithms, have provided new insights into ...
Citation: Arthritis Res Ther 2003 5:279 -
Intravenous immunoglobulin treatment of four patients with juvenile polyarticular arthritis associated with persistent parvovirus B19 infection and antiphospholipid antibodies
Children with rheumatic oligoarthritis and polyarthritis frequently establish persistent parvovirus B19 infections that may be associated with the production of antiphospholipid antibodies (anti-PL IgG). In th...
Citation: Arthritis Res Ther 2003 6:R1 -
Quantitative biomarker analysis of synovial gene expression by real-time PCR
Synovial biomarker analysis in rheumatoid arthritis can be used to evaluate drug effect in clinical trials of novel therapeutic agents. Previous studies of synovial gene expression for these studies have mainl...
Citation: Arthritis Res Ther 2003 5:R352 -
Differential gene expression in pristane-induced arthritis susceptible DA versus resistant E3 rats
Arthritis susceptibility genes were sought by analysis of differential gene expression between pristane-induced arthritis (PIA)-susceptible DA rats and PIA-resistant E3 rats. Inguinal lymph nodes of naïve anim...
Citation: Arthritis Res Ther 2003 5:R361 -
Are synovial biopsies of diagnostic value?
Synovial tissue is readily accessible by closed needle or arthroscopic biopsy. These techniques provide adequate tissue for most diagnostic requirements. Examination of synovial tissue can assist in the diagno...
Citation: Arthritis Res Ther 2003 5:271 -
B cell depletion in autoimmune disease
The CD20 cell marker appears early in the process of B cell development. In this review we focus on the results of attempts to utilize B cell depletion based on the use of a chimeric monoclonal antibody (MAb) ...
Citation: Arthritis Res Ther 2003 5(Suppl 4):S17 -
Targeting B cells for the treatment of rheumatoid arthritis
The role of B cells in rheumatoid arthritis (RA) has been debated for decades. However, recent clinical trial data indicating that depletion of B cells in RA patients is of therapeutic benefit has validated th...
Citation: Arthritis Res Ther 2003 5(Suppl 4):S7 -
Etanercept versus etanercept plus methotrexate: a registry-based study suggesting that the combination is clinically more efficacious
Etanercept can be used both as monotherapy and in combination with methotrexate (MTX), but direct comparisons of these two options have not yet been reported. In order to compare the results seen in actual pra...
Citation: Arthritis Res Ther 2003 5:R347 -
From antibody insult to fibrosis in neonatal lupus - the heart of the matter
Few diseases exemplify the integration of research from bench to bedside as well as neonatal lupus, often referred to as a model of passively acquired autoimmunity. In essence, this disease encompasses two pat...
Citation: Arthritis Res Ther 2003 5:266 -
Neural immune pathways and their connection to inflammatory diseases
Inflammation and inflammatory responses are modulated by a bidirectional communication between the neuroendocrine and immune system. Many lines of research have established the numerous routes by which the imm...
Citation: Arthritis Res Ther 2003 5:251 -
Fortieth Anniversary of APLAR
Citation: Arthritis Res Ther 2003 5(Suppl 3):175 -
Evidence for an IFN-inducible gene, Ifi202, in the susceptibility to systemic lupus
Citation: Arthritis Res Ther 2003 5(Suppl 3):152 -
The synovial cadherin (cadherin-11) mediates tissue formation and promotes invasion of fibroblast-like synoviocytes
Citation: Arthritis Res Ther 2003 5(Suppl 3):148 -
Evidence for functional variation of the death receptor 3 gene predisposing rheumatoid arthritis
Citation: Arthritis Res Ther 2003 5(Suppl 3):115 -
Comparison of the nodule and synovial lesions of rheumatoid arthritis
Citation: Arthritis Res Ther 2003 5(Suppl 3):113 -
Novel tools for molecular analysis in synovium
Citation: Arthritis Res Ther 2003 5(Suppl 3):81 -
OLF1/EBF-associated zinc finger protein gene: a novel lupus susceptibility locus on chromosome 16q identified in a Chinese cohort
Citation: Arthritis Res Ther 2003 5(Suppl 3):77 -
Immunologic reactants in the pathogenesis of atherosclerosis in rheumatic diseases
Citation: Arthritis Res Ther 2003 5(Suppl 3):44 -
Candidate targets for antibody therapy of rheumatoid arthritis: CD64 and IL-15
Citation: Arthritis Res Ther 2003 5(Suppl 3):42 -
Albumin-based drug delivery as novel therapeutic approach for rheumatoid arthritis
Citation: Arthritis Res Ther 2003 5(Suppl 3):9 -
Fifty years' experience in resarch for pathogenesis of rheumatoid arthritis.
Citation: Arthritis Res Ther 2003 5(Suppl 3):3